This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Jun;104(6):525-9.

doi: 10.1007/s00392-015-0825-4. Epub 2015 Feb 24.

CT-proET1 predicts pulmonary hemodynamics in Scleroderma-associated pulmonary hypertension

Henrik Ten Freyhaus¹, Daniel Dumitrescu, Sonja Schnorbach, Kai Kappert, Thomas Viethen, Martin Hellmich, Nicolas Hunzelmann, Stephan Rosenkranz

Affiliations

PMID: 25707764
DOI: 10.1007/s00392-015-0825-4

CT-proET1 predicts pulmonary hemodynamics in Scleroderma-associated pulmonary hypertension

Henrik Ten Freyhaus et al. Clin Res Cardiol. 2015 Jun.

. 2015 Jun;104(6):525-9.

doi: 10.1007/s00392-015-0825-4. Epub 2015 Feb 24.

Authors

Henrik Ten Freyhaus¹, Daniel Dumitrescu, Sonja Schnorbach, Kai Kappert, Thomas Viethen, Martin Hellmich, Nicolas Hunzelmann, Stephan Rosenkranz

Affiliation

¹ Klinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Kerpener Str. 62, 50937, Cologne, Germany.

PMID: 25707764
DOI: 10.1007/s00392-015-0825-4

No abstract available

PubMed Disclaimer

Similar articles

Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
Hamaguchi Y, Fujimoto M, Hasegawa M, Matsushita T, Takehara K. Hamaguchi Y, et al. J Dermatol Sci. 2009 Jul;55(1):66-7. doi: 10.1016/j.jdermsci.2009.02.013. Epub 2009 Apr 1. J Dermatol Sci. 2009. PMID: 19342201 No abstract available.
Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
Sasahara AA. Sasahara AA. J Rheumatol. 2009 Apr;36(4):665-6. doi: 10.3899/jrheum.081322. J Rheumatol. 2009. PMID: 19342719 No abstract available.
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult.
Hesselstrand R, Wildt M, Ekmehag B, Wuttge DM, Scheja A. Hesselstrand R, et al. Scand J Rheumatol. 2011 Mar;40(2):127-32. doi: 10.3109/03009742.2010.508751. Epub 2010 Sep 21. Scand J Rheumatol. 2011. PMID: 20858146
Pulmonary hypertension: screening and evaluation in scleroderma.
York M, Farber HW. York M, et al. Curr Opin Rheumatol. 2011 Nov;23(6):536-44. doi: 10.1097/BOR.0b013e32834ba6a7. Curr Opin Rheumatol. 2011. PMID: 21934501 Review.
Pulmonary vascular aspects of systemic sclerosis.
Wallman LL, Penny R, Williamson DJ. Wallman LL, et al. Aust N Z J Med. 1996 Apr;26(2):150-3. doi: 10.1111/j.1445-5994.1996.tb00876.x. Aust N Z J Med. 1996. PMID: 8744610 Review. No abstract available.

See all similar articles

Cited by

Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E. Behringer A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2016 Apr;389(4):369-79. doi: 10.1007/s00210-015-1205-3. Epub 2016 Jan 7. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 26742933
The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR.
Gumkowska-Sroka O, Chudek A, Owczarek A, Kuźnik-Trocha K, Kotyla K, Kurdybacha J, Chudek J, Komosińska-Vassev K, Winsz-Szczotka K, Olczyk K, Kotyla P. Gumkowska-Sroka O, et al. Int J Mol Sci. 2025 Apr 22;26(9):3938. doi: 10.3390/ijms26093938. Int J Mol Sci. 2025. PMID: 40362179 Free PMC article.

References

1. Chest. 2006 May;129(5):1313-21 - PubMed
1. J Heart Lung Transplant. 2013 Dec;32(12):1214-21 - PubMed
1. Clin Chem. 2006 Jun;52(6):1144-51 - PubMed
1. PLoS One. 2011 Jan 17;6(1):e14506 - PubMed
1. Ann Rheum Dis. 2007 Jul;66(7):940-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information